Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValveBusiness Wire • 08/06/25
10 stocks favored to gain up to 30% in a sector that has missed this year's rallyMarket Watch • 07/31/25
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 ResultsBenzinga • 07/25/25
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/24/25
Edwards Lifesciences raises annual sales forecast on strong demand for heart devicesReuters • 07/24/25
Curious about Edwards Lifesciences (EW) Q2 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 07/21/25
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, AbbottInvestors Business Daily • 05/28/25
Edwards' New Late-Breaking Data on Severe AS Expected to Boost StockZacks Investment Research • 05/23/25
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical OutcomesBusiness Wire • 05/22/25
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care ConferenceBusiness Wire • 05/06/25
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic StenosisBusiness Wire • 05/01/25
EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View RaisedZacks Investment Research • 04/24/25